NDC 61755-013

Evkeeza

Evinacumab

Evkeeza is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Regeneron Pharmaceuticals, Inc.. The primary component is Evinacumab.

Product ID61755-013_316a2495-6f62-4997-87db-0555b219fe23
NDC61755-013
Product TypeHuman Prescription Drug
Proprietary NameEvkeeza
Generic NameEvinacumab
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-02-11
Marketing CategoryBLA / BLA
Application NumberBLA761181
Labeler NameRegeneron Pharmaceuticals, Inc.
Substance NameEVINACUMAB
Active Ingredient Strength150 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 61755-013-01

1 VIAL, SINGLE-USE in 1 CARTON (61755-013-01) > 2.3 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2021-02-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Evkeeza" or generic name "Evinacumab"

NDCBrand NameGeneric Name
61755-010Evkeezaevinacumab
61755-013Evkeezaevinacumab

Trademark Results [Evkeeza]

Mark Image

Registration | Serial
Company
Trademark
Application Date
EVKEEZA
EVKEEZA
88589908 not registered Live/Pending
Regeneron Pharmaceuticals, Inc.
2019-08-23

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.